We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Phospholipid Absorption of a Milk Phospholipid

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01327430
Recruitment Status : Completed
First Posted : April 1, 2011
Last Update Posted : April 1, 2011
Information provided by:

Study Description
Brief Summary:
The aim of the study is to investigate parameters of the lipid metabolism in plasma and feces of healthy subjects after a dietary supplementation of different dosages of milk phospholipids.

Condition or disease Intervention/treatment
Healthy Dietary Supplement: Milk phospholipid

Detailed Description:

To date the mechanisms for the intestinal absorption of glycerophosphates and sphingolipids are not completely investigated. It is assumed, that sphingolipids and sterols compete for intestinal absorption. In addition it is unclear, if a dietary phospholipid supplementation may influence the phospholipid concentration in plasma.

To evaluate the effect of a dietary phospholipid supplementation 15 healthy female subjects received over 10 days daily 3 g of milk phospholipids stirred in a dairy product. During the following 10 days the subjects were supplemented with daily 6 g milk phospholipid. Finally, the subjects received over 10 days 6 g of the milk phospholipid in a dairy product and 2 g of plant sterols serving a commercial product.

Study Design

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 15 participants
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Basic Science
Official Title: Effect of a Milk Phospholipid Supplementation on the Lipid Metabolism in Healthy Volunteers
Study Start Date : May 2010
Primary Completion Date : June 2010
Study Completion Date : June 2010
Arms and Interventions

Arm Intervention/treatment
Experimental: Phospholipid supplementation
Supplementation of milk phospholipid
Dietary Supplement: Milk phospholipid
During day 1 until 10 the subjects were supplemented with daily 3 g milk phospholipids, during the day 11 and 20 the supplementation was increased to daily 6 g, and during the day 21 and 30 the subjects received daily 6 g milk phospholipids and 2 g of plant sterols.

Outcome Measures

Primary Outcome Measures :
  1. Change in plasma phospholipid concentration [ Time Frame: after 0, 10, 20, and 30 days ]

    Total phospholipid concentration

    Individual phospholipid concentration (lyso phosphatidylcholine, phosphatidylcholine, sphingomyelin, phosphatidylethanolamine, phosphatidylinositol)

Secondary Outcome Measures :
  1. Plasma lipids [ Time Frame: after 0,10,20, and 30 days ]

    Fatty acid fraction (total fatty acid distribution, phospholipid fatty acid distribution)

    Cholesterol fraction (total cholesterol, LDL cholesterol, HDL cholesterol)

    Triacylglycerides fraction

  2. Fecal lipids [ Time Frame: after 0,10,20, and 30 days ]
    Fecal lipids (crude fat, total phospholipids, sterols, bile acids)

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   30 Years to 45 Years   (Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes

Inclusion Criteria:

  • female
  • age: between 30 and 45 years

Exclusion Criteria:

  • metabolic diseases
  • arteriosclerosis
  • pregnancy and breast feeding
Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01327430

Friedrich Schiller University of Jena, Department of Nutritional Physiology
Jena, Thuringia, Germany, 07743
Sponsors and Collaborators
University of Jena
Principal Investigator: Gerhard Jahreis, Prof. Dr. Friedrich Schiller University, Department of Nutritional Physiology
More Information

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Prof. Dr. G. Jahreis, Friedrich Schiller University of Jena, Department of Nutritional Physiology
ClinicalTrials.gov Identifier: NCT01327430     History of Changes
Other Study ID Numbers: LSEP H44-10
First Posted: April 1, 2011    Key Record Dates
Last Update Posted: April 1, 2011
Last Verified: March 2011

Keywords provided by University of Jena: